Warning letter
Allosource, Inc.: warning letter of Jul 2, 2002
FDA warning letter UCM146793 · Denver District Office
Key facts
| Reference number | UCM146793 |
|---|---|
| Company | Allosource, Inc. |
| Subject | Human Issue Intended for Transplantation |
| Issue date | Jul 2, 2002 |
| Posted date | Jul 2, 2002 |
| Issuing office | Denver District Office |
| Product type | Unknown |
| Country | 3 |
| Inspection city | Centennial |
| Inspection ZIP | 80111-6422 |
| Inspection start date | Feb 11, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: